http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-216456090-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf37dac778fdba643628dc86519f4896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 |
| filingDate | 2021-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca207b6e0bd726a77159328c6f39699d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00758b65bd03c33ff1166274dbbdaca7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1827e0777b891c93c397e33d4a6902f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf3f3d8e910abf19ed00e4e1637070e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9638aff04dd1f21296033f09d0a912e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_035dd5ca9fa0f8bd657f6c319f305cc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f4e489ca45e62932ef003ef37e17f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_991fa9cccf63de42d69b3e86f2716169 |
| publicationDate | 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-216456090-U |
| titleOfInvention | A nano-drug carrier with tumor cell membrane targeting based on light-triggered reactive oxygen species |
| abstract | The utility model discloses a nano-drug carrier with tumor cell membrane targeting based on light-triggered reactive oxygen species sensitivity, which comprises a drug-carrying inner core layer, and the drug-carrying inner core layer is interwoven by polymer polymer drug-carrying micelles with reactive oxygen species sensitivity. Thus, a target recognition layer, a negative charge layer and a protective layer are sequentially arranged outside the drug-loaded inner core layer. The utility model can improve the solubility of the drug, greatly prolong the action time of the drug, greatly increase the tumor distribution of the drug, and simultaneously trigger the active oxygen Realize the targeted and controlled release of drugs in tumor cell membranes, improve bioavailability, realize photodynamic conversion effect, and improve system biosafety. At the same time, it can also guide anti-tumor by tracking the dynamic position of nanoparticles in in vitro cells or in vivo tissues treatment process. |
| priorityDate | 2021-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.